Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: ursodeoxycholic acid (UDCA) who have an inadequate response to UDCA ×

ursodeoxycholic acid (UDCA) who have an inadequate response to UDCA

This drug is selected. Its supporting articles are shown below.

ursodeoxycholic acid (UDCA) who have an inadequate response to UDCA2

Articles mentioning ursodeoxycholic acid (UDCA) who have an inadequate response to UDCA

2 articles · page 1 of 1

P54 36 months of treatment with seladelpar is associated with stable or improved liver stiffness in patients with primary biliary cholangitis

gutjnl · abstract · 2026-06-23 · 1 matching annotations

91.5%

seladelpar ursodeoxycholic acid (UDCA) who have an inadequate response to UDCA SEL UDCA primary biliary cholangitis (PBC)PBC NCT03301506 NCT04620733

…fness by baseline subgroups.Baseline was defined at the time of seladelpar initiation.n = the number of evaluable patients at each time po…

P62 Seladelpar linked to sustained reduction in cholestatic markers with consistent safety profile in PBC up to 48 months in ASSURE

gutjnl · abstract · 2026-06-23 · 1 matching annotations

86.0%

seladelpar SEL ursodeoxycholic acid (UDCA) who have an inadequate response to UDCA primary biliary cholangitis (PBC)PBC NCT04620733 NCT03301506

…n (B), ALP % change from BL (C) through 36 months of open-label seladelpar treatmentn/N = number of responders at each time point/total nu…